Ptc Therapeutics, Inc. · NASDAQ:PTCT

Boulding Mark Elliott sold 2,073 Ptc Therapeutics, Inc. shares (Form 4)

Traded Oct 5 to Oct 6, 2026 · Filed Oct 7, 2026

From Oct 5 to Oct 6, 2026, Boulding Mark Elliott (EXEC. VP AND CLO) sold 2,073 Ptc Therapeutics, Inc. shares at an average US$64.06 for US$133K under a trading plan, leaving 105,272 shares. Filed Oct 7, 2026 (Form 4).

Sold
2,073 shares
Price
US$64.06 average (US$64.03 to US$64.16)
Value
US$133K
Holding after
105,272 shares
Trading plan
Yes (Made under a plan set in advance)
Role
EXEC. VP AND CLO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Oct 5, 2026Common StockOption exercise1,638US$39.42106,910Direct
Oct 5, 2026Common StockSale1,638US$64.03105,272Direct
Oct 6, 2026Common StockOption exercise435US$39.42105,707Direct
Oct 6, 2026Common StockSale435US$64.16105,272Direct

Source

View original at SEC

Related